ASML publishes agenda Annual General Meeting 2024
ASML publishes agenda Annual General Meeting 2024
Veldhoven, the Netherlands, March 11, 2024 – Today, ASML Holding NV (ASML) has published the agenda for the Annual General Meeting (AGM), which will be held in ASML’s Twinscan Auditorium in Veldhoven on Wednesday, April 24, 2024, starting at 14:00 CET.
The AGM will be organized in a hybrid format. Shareholders may attend the AGM in person or virtually.
The agenda with the explanatory notes and other meeting documents are available on ASML’s website asml.com/agm2024.
Media Relations contacts | Investor Relations contacts |
Monique Mols +31 6 5284 4418 | Skip Miller +1 480 235 0934 |
Sarah de Crescenzo +1 925 899 8985 | Marcel Kemp +31 40 268 6494 |
Karen Lo +886 939788635 | Peter Cheang +886 3 659 6771 |
About ASML
ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity's toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across EMEA, the US and Asia. Every day, ASML’s more than 42,400 employees (FTE) challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML – our products, technology and career opportunities – at www.asml.com.
Attachment
-
Markets Brief: AI Leaders Excel in Earnings Season
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth